Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations

Mitochondrial dysfunction is a common pathological hallmark in various inflammatory and degenerative diseases of the central nervous system, including multiple sclerosis (MS). We previously showed that oxidative stress alters axonal mitochondria, limiting their transport and inducing conformational...

Full description

Bibliographic Details
Main Authors: Bimala Malla, Samuel Cotten, Rebecca Ulshoefer, Friedemann Paul, Anja E. Hauser, Raluca Niesner, Helena Bros, Carmen Infante-Duarte
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/2040622320944773
id doaj-f1a08ce40e2d4b1bb4a20ffc450445fc
record_format Article
spelling doaj-f1a08ce40e2d4b1bb4a20ffc450445fc2020-11-25T03:26:54ZengSAGE PublishingTherapeutic Advances in Chronic Disease2040-62312020-08-011110.1177/2040622320944773Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterationsBimala MallaSamuel CottenRebecca UlshoeferFriedemann PaulAnja E. HauserRaluca NiesnerHelena BrosCarmen Infante-DuarteMitochondrial dysfunction is a common pathological hallmark in various inflammatory and degenerative diseases of the central nervous system, including multiple sclerosis (MS). We previously showed that oxidative stress alters axonal mitochondria, limiting their transport and inducing conformational changes that lead to axonal damage. Teriflunomide (TFN), an oral immunomodulatory drug approved for the treatment of relapsing forms of MS, reversibly inhibits dihydroorotate dehydrogenase (DHODH). DHODH is crucial for de novo pyrimidine biosynthesis and is the only mitochondrial enzyme in this pathway, thus conferring a link between inflammation, mitochondrial activity and axonal integrity. Here, we investigated how DHODH inhibition may affect mitochondrial behavior in the context of oxidative stress. We employed a model of transected murine spinal roots, previously developed in our laboratory. Using confocal live imaging of axonal mitochondria, we showed that in unmanipulated axons, TFN increased significantly the mitochondria length without altering their transport features. In mitochondria challenged with 50 µM hydrogen peroxide (H 2 O 2 ) to induce oxidative stress, the presence of TFN at 1 µM concentration was able to restore mitochondrial shape, motility, as well as mitochondrial oxidation potential to control levels. No effects were observed at 5 µM TFN, while some shape and motility parameters were restored to control levels at 50 µM TFN. Thus, our data demonstrate an undescribed link between DHODH and mitochondrial dynamics and point to a potential neuroprotective effect of DHODH inhibition in the context of oxidative stress-induced damage of axonal mitochondria.https://doi.org/10.1177/2040622320944773
collection DOAJ
language English
format Article
sources DOAJ
author Bimala Malla
Samuel Cotten
Rebecca Ulshoefer
Friedemann Paul
Anja E. Hauser
Raluca Niesner
Helena Bros
Carmen Infante-Duarte
spellingShingle Bimala Malla
Samuel Cotten
Rebecca Ulshoefer
Friedemann Paul
Anja E. Hauser
Raluca Niesner
Helena Bros
Carmen Infante-Duarte
Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
Therapeutic Advances in Chronic Disease
author_facet Bimala Malla
Samuel Cotten
Rebecca Ulshoefer
Friedemann Paul
Anja E. Hauser
Raluca Niesner
Helena Bros
Carmen Infante-Duarte
author_sort Bimala Malla
title Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
title_short Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
title_full Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
title_fullStr Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
title_full_unstemmed Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
title_sort teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
publisher SAGE Publishing
series Therapeutic Advances in Chronic Disease
issn 2040-6231
publishDate 2020-08-01
description Mitochondrial dysfunction is a common pathological hallmark in various inflammatory and degenerative diseases of the central nervous system, including multiple sclerosis (MS). We previously showed that oxidative stress alters axonal mitochondria, limiting their transport and inducing conformational changes that lead to axonal damage. Teriflunomide (TFN), an oral immunomodulatory drug approved for the treatment of relapsing forms of MS, reversibly inhibits dihydroorotate dehydrogenase (DHODH). DHODH is crucial for de novo pyrimidine biosynthesis and is the only mitochondrial enzyme in this pathway, thus conferring a link between inflammation, mitochondrial activity and axonal integrity. Here, we investigated how DHODH inhibition may affect mitochondrial behavior in the context of oxidative stress. We employed a model of transected murine spinal roots, previously developed in our laboratory. Using confocal live imaging of axonal mitochondria, we showed that in unmanipulated axons, TFN increased significantly the mitochondria length without altering their transport features. In mitochondria challenged with 50 µM hydrogen peroxide (H 2 O 2 ) to induce oxidative stress, the presence of TFN at 1 µM concentration was able to restore mitochondrial shape, motility, as well as mitochondrial oxidation potential to control levels. No effects were observed at 5 µM TFN, while some shape and motility parameters were restored to control levels at 50 µM TFN. Thus, our data demonstrate an undescribed link between DHODH and mitochondrial dynamics and point to a potential neuroprotective effect of DHODH inhibition in the context of oxidative stress-induced damage of axonal mitochondria.
url https://doi.org/10.1177/2040622320944773
work_keys_str_mv AT bimalamalla teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT samuelcotten teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT rebeccaulshoefer teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT friedemannpaul teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT anjaehauser teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT ralucaniesner teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT helenabros teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
AT carmeninfanteduarte teriflunomidepreservesperipheralnervemitochondriafromoxidativestressmediatedalterations
_version_ 1724590696726265856